Publications
Detailed Information
Use of Hormonal Protection for Chemotherapy-induced Gonadotoxicity
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, S. Samuel | - |
dc.contributor.author | Lee, Jung Ryeol | - |
dc.contributor.author | Jee, Byung Chul | - |
dc.contributor.author | Suh, Chang Suk | - |
dc.contributor.author | Ting, Alison | - |
dc.contributor.author | Petroff, Brian | - |
dc.contributor.author | Kim, Seok Hyun | - |
dc.date.accessioned | 2012-06-04T06:13:14Z | - |
dc.date.available | 2012-06-04T06:13:14Z | - |
dc.date.issued | 2010-12 | - |
dc.identifier.citation | CLINICAL OBSTETRICS AND GYNECOLOGY; Vol.53 4; 740-752 | ko_KR |
dc.identifier.issn | 0009-9201 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76789 | - |
dc.description.abstract | It is still controversial that GnRH agonist (GnRHa) protects ovarian function from chemotherapy-induced gonadotoxicity. Indeed, the results of many studies related to this issue are neither consistent nor convincing because of the weak study design and the inadequate sample size. We identified 11 prospective controlled studies (8 nonrandomized and 3 randomized) for the systemic review and meta-analysis. The meta-analysis showed that GnRHa cotreatment during chemotherapy can protect ovarian function. However, it is worthy to note that the result of this meta-analysis is influenced by nonrandomized studies. The protective effect of GnRHa will remain elusive until the currently ongoing large, prospective, randomized studies are completed. In addition, tamoxifen, a selective estrogen receptor modulator, may have the protective effect against loss of follicles and ovarian function, which was caused by chemotherapy. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | ko_KR |
dc.subject | fertility preservation | ko_KR |
dc.subject | GnRH agonist | ko_KR |
dc.subject | tamoxifen | ko_KR |
dc.subject | chemotherapy | ko_KR |
dc.subject | cancer | ko_KR |
dc.subject | gonadotoxicity | ko_KR |
dc.title | Use of Hormonal Protection for Chemotherapy-induced Gonadotoxicity | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 이정렬 | - |
dc.contributor.AlternativeAuthor | 조병철 | - |
dc.contributor.AlternativeAuthor | 서창석 | - |
dc.contributor.AlternativeAuthor | 김석현 | - |
dc.identifier.doi | 10.1097/GRF.0b013e3181f96cb1 | - |
dc.citation.journaltitle | CLINICAL OBSTETRICS AND GYNECOLOGY | - |
dc.description.citedreference | Nitzschke M, 2010, ARCH GYNECOL OBSTET, V282, P83, DOI 10.1007/s00404-009-1308-5 | - |
dc.description.citedreference | Badawy A, 2009, FERTIL STERIL, V91, P694, DOI 10.1016/j.fertnstert.2007.12.044 | - |
dc.description.citedreference | Huang YH, 2009, GYNECOL ONCOL, V112, P409, DOI 10.1016/j.ygyno.2008.09.044 | - |
dc.description.citedreference | Ting AY, 2008, CANCER PREV RES, V1, P546, DOI 10.1158/1940-6207.CAPR-08-0015 | - |
dc.description.citedreference | Huser M, 2008, HUM REPROD, V23, P863, DOI 10.1093/humrep/den005 | - |
dc.description.citedreference | Blumenfeld Z, 2008, FERTIL STERIL, V89, P166, DOI 10.1016/j.fertnstert.2007.02.010 | - |
dc.description.citedreference | Andersen J, 2008, ACTA ONCOL, V47, P718, DOI 10.1080/02841860802014882 | - |
dc.description.citedreference | Jordan VC, 2007, J CLIN ONCOL, V25, P5815, DOI 10.1200/JCO.2007.11.3886 | - |
dc.description.citedreference | Blumenfeld Z, 2007, ONCOLOGIST, V12, P1044, DOI 10.1634/theoncologist.12-9-1044 | - |
dc.description.citedreference | Potolog-Nahari C, 2007, GYNECOL ENDOCRINOL, V23, P290, DOI 10.1080/09513590701327661 | - |
dc.description.citedreference | GIUSEPPE L, 2007, HEMATOLOGY, V12, P141 | - |
dc.description.citedreference | CASTELOBRANCO C, 2007, FERTIL STERIL, V87, P702 | - |
dc.description.citedreference | Burns KC, 2006, J PEDIAT HEMATOL ONC, V28, P350 | - |
dc.description.citedreference | Desmeules P, 2006, TOXICOL SCI, V90, P500, DOI 10.1093/toxsci/kfj086 | - |
dc.description.citedreference | Kim SS, 2006, FERTIL STERIL, V85, P1, DOI 10.1016/j.fertnstert.2005.04.071 | - |
dc.description.citedreference | Kossoy G, 2005, ONCOL REP, V14, P1317 | - |
dc.description.citedreference | Somers EC, 2005, ARTHRITIS RHEUM, V52, P2761, DOI 10.1002/art.21263 | - |
dc.description.citedreference | Dann EJ, 2005, HUM REPROD, V20, P2247, DOI 10.1093/humrep/dei018 | - |
dc.description.citedreference | Danforth DR, 2005, FERTIL STERIL, V83, P1333, DOI 10.1016/j.fertnstert.2004.12.030 | - |
dc.description.citedreference | BLUMENFELD Z, 2005, J NATL CANC I MONOGR, V34, P40 | - |
dc.description.citedreference | Meirow D, 2004, HUM REPROD, V19, P1294, DOI 10.1093/humrep/deh257 | - |
dc.description.citedreference | Mardesic T, 2004, EUR J GYNAECOL ONCOL, V25, P90 | - |
dc.description.citedreference | Wickerham DL, 2002, J CLIN ONCOL, V20, P2758 | - |
dc.description.citedreference | Pacheco BP, 2001, GYNECOL ONCOL, V81, P391 | - |
dc.description.citedreference | Ezzat AA, 2000, MED ONCOL, V17, P39 | - |
dc.description.citedreference | Gosden RG, 1997, HUM REPROD, V12, P2483 | - |
dc.description.citedreference | SMITH DC, 1995, CANCER CHEMOTH PHARM, V36, P65 | - |
dc.description.citedreference | ATAYA K, 1995, J CLIN ENDOCR METAB, V80, P790 | - |
dc.description.citedreference | ATAYA K, 1995, BIOL REPROD, V52, P365 | - |
dc.description.citedreference | MONTZ FJ, 1991, CANCER RES, V51, P2124 | - |
dc.description.citedreference | PLOWCHALK DR, 1991, TOXICOL APPL PHARM, V107, P472 | - |
dc.description.citedreference | BLEYER WA, 1990, CA-CANCER J CLIN, V40, P355 | - |
dc.description.citedreference | WAXMAN JH, 1987, CANCER CHEMOTH PHARM, V19, P159 | - |
dc.description.citedreference | ATAYA KM, 1985, CANCER RES, V45, P3651 | - |
dc.description.citedreference | ROSE DP, 1980, CANCER RES, V40, P4043 | - |
dc.description.tc | 5 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.